PGR and breast carcinoma: Breast cancer produces highly heterogeneous tumors that are classified into clinically relevant subtypes based on the status of the estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2) and Ki67.